29.40
Immunocore Holdings Plc Adr Azioni (IMCR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
8.67%
115.93
|
106.68 | 104.48 | 103.69 | 97.96 |
| Cost Of Revenue |
150.69%
1.088
|
0.434 | 2.703 | 0.513 | 1.04 |
|
|
15.96%
43.89
|
37.85 | - | - | - |
| Operating Income/Loss |
141.15%
-2.996
|
7.28 | -19.69 | -7.171 | -14.88 |
| Income/Loss From Continuing Operations Before Tax |
103.87%
-0.514
|
13.27 | -15.79 | 0.304 | -9.694 |
| Income Tax Expense/Benefit |
2.33%
0.294
|
0.301 | 14.27 | 0.481 | 0.606 |
| Net Income/Loss |
106.23%
-0.808
|
12.97 | -30.06 | -0.177 | -10.30 |
| Basic Average Shares |
0.43%
50.97
|
50.75 | 0.083 | 50.40 | 50.29 |
| Diluted Average Shares |
3.70%
50.97
|
52.93 | 0.083 | 50.40 | 50.29 |
| Basic Earnings Per Share |
107.69%
-0.02
|
0.26 | -0.60 | - | -0.20 |
| Diluted Earnings Per Share |
108.00%
-0.02
|
0.25 | -0.60 | - | -0.20 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):